Ewing‐like sarcomas are characterized by different responsiveness to standard therapy than Ewing sarcoma, with superior outcomes in the case of BCOR‐CCNB3 tumors and inferior outcomes with CIC‐DUX4 sarcomas.23, 24. This evidence concerns the gene CCNB3 and Ewing sarcoma.